CLASS II ONGOING Device recall · Reported 23 Jul 2025 · FDA Enforcement Report

Empowr 3d Knee Tibial Insert - E-plus Empowr 3d Kneetm Ins, Ve recalled

Encore Medical is recalling Empowr 3d Knee Tibial Insert - E-plus Empowr 3d Kneetm Ins, Ve, distributed in 18 states. The recall was initiated on 2 Jun 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: Item: 341-12-711 GTIN: 00888912166980 Lot: 115T1077
Quantity recalled20

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2126-2025
FDA event ID
97048
Recalling firm
Encore Medical, Austin, TX
Classification
Class II
Status
Ongoing
Recall initiated
2 Jun 2025
FDA classified
17 Jul 2025
Reported
23 Jul 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

2 Jun 2025Recall initiated by company
17 Jul 2025Classified by FDA+45 days
23 Jul 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to packaging discrepancy with the incorrect tibial inserts/implants being packaged. The use of this product may result in the incorrect product being selected. This could result in a revision surgery if used.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Brand Name: EMPOWR 3D KNEE TIBIAL INSERT - E-PLUS Product Name: EMPOWR 3D KNEETM INS, 11L 12MM, VE Model/Catalog Number: 341-12-711 Software Version: NA Product Description: Enovis" knee devices are intended for treatment of patients who are candidates for knee arthroplasty per the Indication for use. While total knee replacements are not intended to withstand activity levels and loads of normal healthy bone, they are a means of restoring mobility and reducing pain for many patients. Component: NA

Where it was distributed

U.S Distribution to states of: AZ, IA, ID, IL, IN, LA, MI, MO, MS, NE, NY, OK, OR, PR, SD, UT, VA, and WA

ArizonaIowaIdahoIllinoisIndianaLouisianaMichiganMissouriMississippiNebraskaNew YorkOklahomaOregonPuerto RicoSouth DakotaUtahVirginiaWashington

Questions about this recall

Why was it recalled?

Due to packaging discrepancy with the incorrect tibial inserts/implants being packaged. The use of this product may result in the incorrect product being selected. This could result in a revision surgery if used.

Which lots are affected?

Lot Code: Item: 341-12-711 GTIN: 00888912166980 Lot: 115T1077

Where was it sold?

U.S Distribution to states of: AZ, IA, ID, IL, IN, LA, MI, MO, MS, NE, NY, OK, OR, PR, SD, UT, VA, and WA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 97048

More recalls from Encore Medical

All 99

Other Hip & Knee Implants recalls

All 3,110